ID

38832

Descripción

Variation of Glucose Values at Early Stages of Diabetes - Continuous Glucose Monitoring; ODM derived from: https://clinicaltrials.gov/show/NCT02294370

Link

https://clinicaltrials.gov/show/NCT02294370

Palabras clave

Versiones (1)
  1. 7/11/19 7/11/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

7 de noviembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus, Type 2 NCT02294370

Inglés

Eligibility Diabetes Mellitus, Type 2 NCT02294370

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
individuals with impaired glucose tolerance (2h plasma glucose during oral glucose tolerance test >7.8-11.1 mmol/l, n=50) or with type 2 diabetes (fasting plasma glucose > 7.0 mmol/l and/or 2h plasma glucose > 11.1 mmol/l on two occasions, or both criteria fulfilled in the same oral glucose tolerance test while not pregnant, n=50) with short duration (<3 years); 40 from padova university hospital, 60 from the botnia study or the ppp (prevalence, prediction, prevention)-botnia study in finland.
Descripción

Decreased glucose tolerance | Plasma Glucose Measurement Oral Glucose Tolerance Test | Diabetes Mellitus, Non-Insulin-Dependent | Plasma fasting glucose measurement | Pregnancy Absent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0151671
UMLS CUI [2,1]
C0202042
UMLS CUI [2,2]
C0029161
UMLS CUI [3]
C0011860
UMLS CUI [4]
C0583513
UMLS CUI [5,1]
C0032961
UMLS CUI [5,2]
C0332197
age 40-75 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
medication with: insulin, glucagon-like peptide-1 (glp-1)-analogues, sulphonylureas, oral corticosteroids, thyreostatic agents or thyroid hormone, luteinizing-hormone-releasing hormone (lhrh) analogues
Descripción

Insulin | GLP-1 Analogue | Sulfonylurea | Adrenal Cortex Hormones Oral | Thyreostatic therapy | Thyroid Hormones | LH-RH Analogs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021641
UMLS CUI [2]
C3273809
UMLS CUI [3]
C0038766
UMLS CUI [4,1]
C0001617
UMLS CUI [4,2]
C1527415
UMLS CUI [5]
C1696471
UMLS CUI [6]
C0040135
UMLS CUI [7]
C1518041
pregnancy
Descripción

Pregnancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
known changes in retinal fundus photographs
Descripción

Change Ophthalmoscopy Retinal

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392747
UMLS CUI [1,2]
C0029090
UMLS CUI [1,3]
C0035298
known, microalbuminuria
Descripción

Microalbuminuria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0730345
hba1c >8%
Descripción

Hemoglobin A1c measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0474680
fasting plasma glucose >10 mmol/l
Descripción

Plasma fasting glucose measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0583513
medication with metformin, glitazones, gliptins (or acarbose) is allowed but gliptins and acarbose need to be stopped 2 days before testing and during the study
Descripción

Metformin allowed | Thiazolidinediones allowed | Gliptins To be stopped | Acarbose To be stopped

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C0683607
UMLS CUI [2,1]
C1257987
UMLS CUI [2,2]
C0683607
UMLS CUI [3,1]
C1827106
UMLS CUI [3,2]
C1272691
UMLS CUI [4,1]
C0050393
UMLS CUI [4,2]
C1272691
Volver a la parte superior de la página

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT02294370

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Decreased glucose tolerance | Plasma Glucose Measurement Oral Glucose Tolerance Test | Diabetes Mellitus, Non-Insulin-Dependent | Plasma fasting glucose measurement | Pregnancy Absent
Item
individuals with impaired glucose tolerance (2h plasma glucose during oral glucose tolerance test >7.8-11.1 mmol/l, n=50) or with type 2 diabetes (fasting plasma glucose > 7.0 mmol/l and/or 2h plasma glucose > 11.1 mmol/l on two occasions, or both criteria fulfilled in the same oral glucose tolerance test while not pregnant, n=50) with short duration (<3 years); 40 from padova university hospital, 60 from the botnia study or the ppp (prevalence, prediction, prevention)-botnia study in finland.
boolean
C0151671 (UMLS CUI [1])
C0202042 (UMLS CUI [2,1])
C0029161 (UMLS CUI [2,2])
C0011860 (UMLS CUI [3])
C0583513 (UMLS CUI [4])
C0032961 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
Age
Item
age 40-75 years
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Insulin | GLP-1 Analogue | Sulfonylurea | Adrenal Cortex Hormones Oral | Thyreostatic therapy | Thyroid Hormones | LH-RH Analogs
Item
medication with: insulin, glucagon-like peptide-1 (glp-1)-analogues, sulphonylureas, oral corticosteroids, thyreostatic agents or thyroid hormone, luteinizing-hormone-releasing hormone (lhrh) analogues
boolean
C0021641 (UMLS CUI [1])
C3273809 (UMLS CUI [2])
C0038766 (UMLS CUI [3])
C0001617 (UMLS CUI [4,1])
C1527415 (UMLS CUI [4,2])
C1696471 (UMLS CUI [5])
C0040135 (UMLS CUI [6])
C1518041 (UMLS CUI [7])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Change Ophthalmoscopy Retinal
Item
known changes in retinal fundus photographs
boolean
C0392747 (UMLS CUI [1,1])
C0029090 (UMLS CUI [1,2])
C0035298 (UMLS CUI [1,3])
Microalbuminuria
Item
known, microalbuminuria
boolean
C0730345 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
hba1c >8%
boolean
C0474680 (UMLS CUI [1])
Plasma fasting glucose measurement
Item
fasting plasma glucose >10 mmol/l
boolean
C0583513 (UMLS CUI [1])
Metformin allowed | Thiazolidinediones allowed | Gliptins To be stopped | Acarbose To be stopped
Item
medication with metformin, glitazones, gliptins (or acarbose) is allowed but gliptins and acarbose need to be stopped 2 days before testing and during the study
boolean
C0025598 (UMLS CUI [1,1])
C0683607 (UMLS CUI [1,2])
C1257987 (UMLS CUI [2,1])
C0683607 (UMLS CUI [2,2])
C1827106 (UMLS CUI [3,1])
C1272691 (UMLS CUI [3,2])
C0050393 (UMLS CUI [4,1])
C1272691 (UMLS CUI [4,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial